Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Ethylmercury Compounds”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1976

[The tissue distribution and the effect of mercury on the hepatic cholesterol biosynthesis following the oral administration of methyl- and ethylmercurial compounds (author's transl)].

Hepatic cholesterol biosynthesis from acetate-1-14C, hepatic cholesterol level and accumulation of mercury into various tissues were examined following oral administration of methyl- or ethyl-mercury to mice (or rat) at next dosage levels, 80 ppm for 10-19 days, 50 ppm for 30 days and 100 ppm for 15 days. The results obtained were as follows. 1. Hepatic cholesterol biosynthesis was elevated at a dose of 80 ppm and decreased at a dose of 50 and 100 ppm. The change of hepatic cholesterol biosynthesis showed the negative correlation with that of cholesterol level. 2. In comparison between methyl-and ethylmercury, the latter accumulated more than the former in liver and spleen, while the former accumulated more than the latter in kidney, cerebum and skeletal muscle. The administration of ethylmercury caused more decrease of body weight, increase of hepatic cholesterol biosynthesis and hepatic cholesterol level than the administration of methylmercury.

Administration, Oral↗
PubMed1984

Octanol/water partition coefficients as a model system for assessing antidotes for methylmercury(II) poisoning, and for studying mercurials with medicinal applications.

1-Octanol/water partition coefficients, [HgII]octanol/[HgII]water, provide a simple but limited model system for aspects of the biological behavior of methylmercury(II) and commonly used organomercury(II) medicinal compounds. In an octanol/water system some widely studied antidotes for mercury poisoning at least partly displace the biological thiols L-cysteine and glutathione from binding to MeHgII at pH 6.9. Addition of the antidote meso-dimercaptosuccinic acid to MeHgII in the presence of glutathione results in formation of metallic mercury. For RHgII derivatives of L-cysteine and glutathione, octanol/water partition coefficients follow the order Ph greater than Et greater than Me. An exceptionally high value for diphenylmercury, compared with PhHgII derivatives of L-cysteine and glutathione, is consistent with reported results of the distribution of mercury compounds in rats. Ethylmercury(II) is partly displaced from thimerosal by L-cysteine and glutathione in the octanol/water system, indicating that the active form of thimerosal in vivo may involve binding of EtHgII to biological ligands.

Animals↗
PubMed1981

Aerobic responses of the cornea to ophthalmic preservatives, measured in vivo.

A micropolarographic system was used to measure the effects of several concentrations of benzalkonium chloride and thimerosal on oxygen uptake by the cornea. Although the threshold of 0.01% found for benzalkonium chloride generally agreed with other criteria (e.g., clinical and histologic) in the current literature, the threshold for thimerosal was somewhat higher, 1.0%, indicating a substantially greater aerobic activity tolerance of the cornea to initial direct exposures of that agent then to benzalkonium chloride.

Animals↗
PubMed1972

Ethyl mercury p-toluene sulfonanilide: lethal and reproductive effects on pheasants.

Ethyl mercury p-toluene sulfonanilide (active ingredient of Ceresan M) at a dietary concentration of 30 parts per million (12.5 parts of mercury per million) was lethal to adult ring-necked pheasants. Egg production and survival of third-week embryos were sharply reduced when breeders were maintained on feed containing 10 parts of this compound per million (4.2 parts of mercury per million).

Aniline Compounds↗
PubMed1982

Light-induced genetic toxicity of thimerosal and benzalkonium chloride in commercial contact lens solutions.

Several commercial solutions used for daily care of contact lenses were tested for mutagenicity in 4 strains of Salmonella and for their ability to induce repairable DNA damage in the E. coli DNA polymerase A- assay. 5 of the 13 solutions tested were positive in the polymerase A- assay. These products demonstrated an increased level of genetic toxicity when the assay was conducted under conditions of illumination with visible light. Investigation of the genetic toxicity of some of their components, specifically the preservatives, indicated that thimerosal and benzalkonium chloride were capable of causing repairable DNA damage. Thimerosal was active only when the plates were incubated under conditions of illumination, and thus was light-induced. Benzalkonium chloride was active under conditions of dark incubation, and its genetic toxicity was enhanced when the plates were irradiated with visible light. These results were confirmed in a parallel experiment, in which cells were treated with the test agent and irradiated for a short period in liquid culture and viable cells then determined. None of the commercial products and none of the components tested, were mutagenic in the Salmonella assay.

Baths↗
PubMed2003

Association between thimerosal-containing vaccine and autism.

CONTEXT: Mercuric compounds are nephrotoxic and neurotoxic at high doses. Thimerosal, a preservative used widely in vaccine formulations, contains ethylmercury. Thus it has been suggested that childhood vaccination with thimerosal-containing vaccine could be causally related to neurodevelopmental disorders such as autism. OBJECTIVE: To determine whether vaccination with a thimerosal-containing vaccine is associated with development of autism. DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study of all children born in Denmark from January 1, 1990, until December 31, 1996 (N = 467 450) comparing children vaccinated with a thimerosal-containing vaccine with children vaccinated with a thimerosal-free formulation of the same vaccine. MAIN OUTCOME MEASURES: Rate ratio (RR) for autism and other autistic-spectrum disorders, including trend with dose of ethylmercury. RESULTS: During 2 986 654 person-years, we identified 440 autism cases and 787 cases of other autistic-spectrum disorders. The risk of autism and other autistic-spectrum disorders did not differ significantly between children vaccinated with thimerosal-containing vaccine and children vaccinated with thimerosal-free vaccine (RR, 0.85 [95% confidence interval [CI], 0.60-1.20] for autism; RR, 1.12 [95% CI, 0.88-1.43] for other autistic-spectrum disorders). Furthermore, we found no evidence of a dose-response association (increase in RR per 25 microg of ethylmercury, 0.98 [95% CI, 0.90-1.06] for autism and 1.03 [95% CI, 0.98-1.09] for other autistic-spectrum disorders). CONCLUSION: The results do not support a causal relationship between childhood vaccination with thimerosal-containing vaccines and development of autistic-spectrum disorders.

Autistic Disorder↗